237 related articles for article (PubMed ID: 12186629)
1. Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes.
Latsis T; Andersen B; Agius L
Biochem J; 2002 Nov; 368(Pt 1):309-16. PubMed ID: 12186629
[TBL] [Abstract][Full Text] [Related]
2. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.
Andersen B; Westergaard N
Biochem J; 2002 Oct; 367(Pt 2):443-50. PubMed ID: 12099891
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glycogenolysis in primary rat hepatocytes by 1, 4-dideoxy-1,4-imino-D-arabinitol.
Andersen B; Rassov A; Westergaard N; Lundgren K
Biochem J; 1999 Sep; 342 Pt 3(Pt 3):545-50. PubMed ID: 10477265
[TBL] [Abstract][Full Text] [Related]
4. Kinetic and functional characterization of 1,4-dideoxy-1, 4-imino-d-arabinitol: a potent inhibitor of glycogen phosphorylase with anti-hyperglyceamic effect in ob/ob mice.
Fosgerau K; Westergaard N; Quistorff B; Grunnet N; Kristiansen M; Lundgren K
Arch Biochem Biophys; 2000 Aug; 380(2):274-84. PubMed ID: 10933882
[TBL] [Abstract][Full Text] [Related]
5. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
Gregus Z; Németi B
Toxicol Sci; 2007 Nov; 100(1):44-53. PubMed ID: 17693424
[TBL] [Abstract][Full Text] [Related]
6. Glucose 6-phosphate causes translocation of phosphorylase in hepatocytes and inactivates the enzyme synergistically with glucose.
Aiston S; Green A; Mukhtar M; Agius L
Biochem J; 2004 Jan; 377(Pt 1):195-204. PubMed ID: 13678417
[TBL] [Abstract][Full Text] [Related]
7. Bioactivity of glycogen phosphorylase inhibitors that bind to the purine nucleoside site.
Hampson LJ; Arden C; Agius L; Ganotidis M; Kosmopoulou MN; Tiraidis C; Elemes Y; Sakarellos C; Leonidas DD; Oikonomakos NG
Bioorg Med Chem; 2006 Dec; 14(23):7835-45. PubMed ID: 16908161
[TBL] [Abstract][Full Text] [Related]
8. Characterization of 1,4-dideoxy-1,4-imino-d-arabinitol (DAB) as an inhibitor of brain glycogen shunt activity.
Walls AB; Sickmann HM; Brown A; Bouman SD; Ransom B; Schousboe A; Waagepetersen HS
J Neurochem; 2008 May; 105(4):1462-70. PubMed ID: 18221367
[TBL] [Abstract][Full Text] [Related]
9. Increased potency and efficacy of combined phosphorylase inactivation and glucokinase activation in control of hepatocyte glycogen metabolism.
Hampson LJ; Agius L
Diabetes; 2005 Mar; 54(3):617-23. PubMed ID: 15734835
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory properties of 1,4-dideoxy-1,4-imino-d-arabinitol (DAB) derivatives acting on glycogen metabolising enzymes.
Díaz-Lobo M; Concia AL; Gómez L; Clapés P; Fita I; Guinovart JJ; Ferrer JC
Org Biomol Chem; 2016 Sep; 14(38):9105-9113. PubMed ID: 27714243
[TBL] [Abstract][Full Text] [Related]
11. Regulation of glycogen metabolism in cultured human muscles by the glycogen phosphorylase inhibitor CP-91149.
Lerín C; Montell E; Nolasco T; García-Rocha M; Guinovart JJ; Gómez-Foix AM
Biochem J; 2004 Mar; 378(Pt 3):1073-7. PubMed ID: 14651477
[TBL] [Abstract][Full Text] [Related]
12. Modulation of glycogen phosphorylase activity affects 5-phosphoribosyl-1-pyrophosphate availability in rat hepatocyte cultures.
Boer P; Sperling O
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1235-9. PubMed ID: 15571236
[TBL] [Abstract][Full Text] [Related]
13. The glycogenic action of protein targeting to glycogen in hepatocytes involves multiple mechanisms including phosphorylase inactivation and glycogen synthase translocation.
Green AR; Aiston S; Greenberg CC; Freeman S; Poucher SM; Brady MJ; Agius L
J Biol Chem; 2004 Nov; 279(45):46474-82. PubMed ID: 15322104
[TBL] [Abstract][Full Text] [Related]
14. Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors.
Ercan-Fang N; Taylor MR; Treadway JL; Levy CB; Genereux PE; Gibbs EM; Rath VL; Kwon Y; Gannon MC; Nuttall FQ
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E366-72. PubMed ID: 15797986
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the interaction between protein phosphatase 1 glycogen-targeting subunit and glycogen phosphorylase increases glycogen synthesis in primary rat hepatocytes.
Zibrova D; Grempler R; Streicher R; Kauschke SG
Biochem J; 2008 Jun; 412(2):359-66. PubMed ID: 18298402
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthesis correlates with androgen-dependent growth arrest in prostate cancer.
Schnier JB; Nishi K; Gumerlock PH; Gorin FA; Bradbury EM
BMC Urol; 2005 Mar; 5():6. PubMed ID: 15790394
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of glycogen phosphorylase stimulates ventromedial hypothalamic nucleus AMP-activated protein kinase: Activity and neuronal nitric oxide synthase protein expression in male rats.
Alhamami HN; Alshamrani A; Briski KP
Physiol Rep; 2017 Dec; 5(23):. PubMed ID: 29199177
[TBL] [Abstract][Full Text] [Related]
18. Glucagon challenge in the rat: a robust method for the in vivo assessment of Glycogen phosphorlyase inhibitor efficacy.
Loxham SJ; Teague J; Poucher SM; De Schoolmeester J; Turnbull AV; Carey F
J Pharmacol Toxicol Methods; 2007; 55(1):71-7. PubMed ID: 16713718
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of phosphorylase is a major component of the mechanism by which insulin stimulates hepatic glycogen synthesis.
Aiston S; Coghlan MP; Agius L
Eur J Biochem; 2003 Jul; 270(13):2773-81. PubMed ID: 12823547
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and anti-hyperglycaemic efficacy of a novel inhibitor of glycogen phosphorylase, 1,4-dideoxy-1,4-imino-d- arabinitol, in glucagon-challenged rats and dogs and in diabetic ob/ob mice.
Mackay P; Ynddal L; Andersen JV; McCormack JG
Diabetes Obes Metab; 2003 Nov; 5(6):397-407. PubMed ID: 14617225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
